Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chuanyang Lu
Observed name:
Lu, Chuanyang
Institutions:
Huaian First People’s Hospital,
Zhejiang University of Technology,
Nanjing Medical University
Observed institutions:
Huaian First People’s Hospital,
Zhejiang University of Technology,
Nanjing Medical University
ORCID:
0000-0001-7640-5774
Observed ORCID:
0000-0001-7640-5774
OpenAlex ID:
A5059855982
Prognostic impact of the controlling nutritional status score in patients with hematologic malignancies: A systematic review and meta-analysis
2022
·
Chuanyang Lu
, Qiuni Chen
, et al.
·
Frontiers in Immunology
·
35
PDF
Prognostic role of controlling nutritional status score in hematological malignancies
2022
·
Yijing Zhang
, Qiuni Chen
, et al.
·
Hematology
·
32
Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed/refractory angioimmunoblastic T-cell lymphoma
2024
·
Mengyan Zhu
, Ning Li
, et al.
·
Blood Cancer Journal
·
26
PDF
The causal effect of inflammatory bowel disease on diffuse large B-cell lymphoma: two-sample Mendelian randomization study
2023
·
Chuanyang Lu
, Qiuni Chen
, et al.
·
Frontiers in Immunology
·
18
The association of COVID-19 with diffuse large B-cell lymphoma: a Mendelian randomization study
2023
·
Qiuni Chen
, Chuanyang Lu
, et al.
·
International Journal of Environmental Health Research
·
9
CDK1 inhibitor RO-3306 enhances BTKi potency in diffuse large B-cell lymphoma by suppressing JAK2/STAT3 signaling
2025
·
Qiuni Chen
, Chuanyang Lu
, et al.
·
International Journal of Biological Macromolecules
·
7
Prognostic significance of CDK1 expression in diffuse large B-Cell lymphoma
2025
·
Qiuni Chen
, Lei Xu
, et al.
·
BMC Cancer
·
7
PDF
The prognostic role of lymphocyte to monocyte ratio (LMR) in patients with Myelodysplastic Neoplasms
2023
·
Chuanyang Lu
, Qiuni Chen
, et al.
·
Hematology
·
7
PDF
Global, regional, and national burden of Hodgkin lymphoma, 1990–2021, and predictions for 2050: an analysis of the global burden of disease study 2021
2025
·
Dongnan Li
, Yunjie Li
, et al.
·
Expert Review of Hematology
·
5
Single-cell transcriptome analysis defines novel molecular subtypes and reveals therapeutic implications of T/myeloid mixed-phenotype acute leukemia
2025
·
Bin Huang
, Wenjie Liu
, et al.
·
Genome Medicine
·
3
The prognostic value of POD24 for multiple myeloma: a comprehensive analysis based on traditional statistics and machine learning
2025
·
Quane Zhang
, Yifan Wang
, et al.
·
BMC Cancer
·
3
PDF
Bruton’s tyrosine kinase inhibitors in diffuse large B-cell lymphoma therapy: critical considerations and future innovations
2026
·
Chuanyang Lu
, Qiuni Chen
, et al.
·
Journal of Translational Medicine
·
1
PDF
Effect of autoimmune diseases on aplastic anemia: a bidirectional two-sample Mendelian randomization study
2026
·
Qiuni Chen
, Chuanyang Lu
, et al.
·
Hematology
·
1
PDF
Target-oriented multi-attribute screening of stress-relief interlayers for B4C/TC4 brazed combinations
2026
·
Weihan Xi
, Tao Chen
, et al.
·
Journal of Materials Science
Resistance to covalent Bruton's tyrosine kinase inhibitors in diffuse large B‑cell lymphoma: Molecular mechanisms and therapeutic implications (Review)
2026
·
Chuanyang Lu
, Tingting Zhou
, et al.
·
International Journal of Oncology
Effect of autoimmune diseases on aplastic anemia: a bidirectional two-sample Mendelian randomization study
2026
·
Chen, Qiuni
, Lu, Chuanyang
, et al.
·
Figshare
Cathepsins effect on diffuse large B cell lymphoma risk: A Mendelian randomization study
2025
·
Chuanyang Lu
, Qiuni Chen
, et al.
·
Medicine
The current status and future trends of BTK inhibitor for diffuse large B cell lymphoma
2024
·
Qiuni Chen
, Lei Xu
, et al.
·
Pharmacological Research
Show more works
View as search
Works count:
20
Citation count:
154
H-index:
7
I10-index:
4
Year
Topic
Type